Chemiesynth board to meet on May 27 for Q4FY26 results

1 min read     Updated on 20 May 2026, 01:45 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Chemiesynth (Vapi) Limited will hold a board meeting on May 27, 2026, to consider audited financial results for Q4 and FY26. The trading window is closed until 48 hours post-results announcement.

powered bylight_fuzz_icon
40810539

*this image is generated using AI for illustrative purposes only.

Chemiesynth (Vapi) Limited has announced that its board of directors will meet on Wednesday, May 27, 2026. The meeting is scheduled to take place at the company's registered office at 03:00 PM. The primary agenda includes the discussion and approval of the audited financial results for the quarter and fiscal year ended March 31, 2026.

Agenda for the Board Meeting

The board will deliberate on key financial documents and compliance requirements. The specific items listed for consideration include:

  • To discuss, consider, approve, and take on record the Audited Financial Results of the Company for the quarter and year ended on March 31, 2026, along with the Auditor's report as per Regulation 33 of SEBI (LODR) Regulations, 2015.
  • Any other items with the permission of the Chair and Majority of Directors.

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading, the trading window for the company's securities has been closed since Wednesday, April 1, 2026. The window will remain closed and shall reopen 48 hours after the declaration of the financial results.

Publication of Results

Following the board meeting, the audited financial results will be uploaded to the company's official website. An extract of the results will also be published in newspapers to ensure broad dissemination of the information to shareholders and the public.

Historical Stock Returns for Chemiesynth Vapi

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%+14.57%+53.45%+69.17%+304.20%

How might Chemiesynth (Vapi) Limited's FY2026 financial results compare to industry peers in the specialty chemicals sector, and what growth trajectory could investors expect going forward?

Following the trading window reopening, what potential stock price movement could be anticipated based on the company's historical post-results performance patterns?

Are there any planned capital expenditure or expansion initiatives that the board might announce alongside the FY2026 financial results that could signal future business direction?

Chemiesynth (Vapi) Limited claims exemption from SEBI Regulation 24A compliance requirements

1 min read     Updated on 16 Apr 2026, 10:47 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Chemiesynth (Vapi) Limited has officially claimed exemption from Regulation 24A of SEBI (LODR) Regulations 2015 for the period ended March 31, 2026, based on its qualification under Regulation 15(2) due to paid-up equity share capital not exceeding ₹10 crore and net worth not exceeding ₹25 crore, exempting it from Annual Secretarial Compliance Report submission requirements.

powered bylight_fuzz_icon
37778053

*this image is generated using AI for illustrative purposes only.

Chemiesynth (Vapi) Limited has declared its exemption from Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the period ended March 31, 2026, citing its eligibility under Regulation 15(2) due to its financial parameters.

Exemption Under Regulation 15(2)

The company has claimed exemption based on its paid-up equity share capital not exceeding ₹10 crore and net worth not exceeding ₹25 crore as on the last day of the previous financial year 2025-2026. This qualification allows the company to seek relief from certain compliance requirements under SEBI regulations.

Parameter: Details
Paid-up Equity Capital: Not exceeding ₹10 crore
Net Worth: Not exceeding ₹25 crore
Reference Period: Financial Year 2025-2026
Exemption Date: April 16, 2026

Secretarial Compliance Report Exemption

Consequently, Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Amendment Regulations 2018 regarding submission of Annual Secretarial Compliance Report shall not be applicable to the company. The declaration was made in accordance with multiple BSE circulars and notices.

Reference Document: Date
BSE Circular: LIST/COMP/10/2019-20 dated February 8, 2019
BSE Circular: May 9, 2019 and May 14, 2019
BSE Notice: 20230316-14 dated March 16, 2023
BSE Notice: 20230410-41 dated April 10, 2023

Official Declaration

The formal communication was submitted to BSE Limited on April 16, 2026, and was digitally signed by Pranali Dholabhai, Company Secretary & Compliance Officer. The company operates under scrip code 539230 on BSE.

Company Profile

Chemiesynth (Vapi) Limited maintains its registered office at Plot No. 27, GIDC, Phase-1, Vapi – 396195, Gujarat, and operates under CIN: L24110GJ1986PLC008634. The company can be reached at compliance@chemiesynth.com and maintains its web presence at https://www.chemiesynth.com .

Historical Stock Returns for Chemiesynth Vapi

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%+14.57%+53.45%+69.17%+304.20%

Will Chemiesynth's exemption from secretarial compliance reporting affect investor confidence or transparency perceptions in the coming years?

How might the company's growth trajectory change if it exceeds the ₹10 crore paid-up capital or ₹25 crore net worth thresholds before 2026?

What strategic advantages could this regulatory exemption provide Chemiesynth in competing with larger chemical companies?

More News on Chemiesynth Vapi

1 Year Returns:+69.17%